This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Antibody Engineering

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Events

Showing 5 of 6 eventsView all events
Featured

Antibody Engineering & Therapeutics US

Delivered as a Hybrid Event from December 12 - 16, 2021, Marriott Marquis San Diego

THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS

Go to site

mRNA Technologies, Therapeutics and Vaccines Digital Week

June 28-30, 2021, Delivered in Eastern Standard Time (EST)

Industry Leaders & Service Providers will showcase the power and diversity of mRNA technologies and applications across discovery, R&D, manufacturing & delivery

Antibody Discovery, Selection and Screening

September 27-29 2021

FREE VIRTUAL WEBINAR SERIES DIVING INTO ANTIBODY DISCOVERY, SELECTION, AND SCREENING

Antibodies, Next-Generation Proteins & Bioconjugates Digital Week

March 1-3, 2021, YOUR HOME OR OFFICE

A series of FREE virtual webinars to access antibody-related learning year-round

Antibody Engineering & Therapeutics Asia

5 - 7 April 2021

THE ONLY EVENT IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN THERAPIES, ADCS, BISPECIFICS AND IMMUNO-ONCOLOGY

Articles & Video

Showing 9 of 62 articles & videoView all articles & video
Featured
Antibody discovery

eBook: Antibody Discovery, Selection & Screening

This ebook uncovers the latest approaches and emerging tools for therapeutic antibody discovery.

Featured
Antibody Engineering & Therapeutics

REPORT: Antibody Engineering & Therapeutics State of the Industry 2021

This report of the antibody engineering and therapeutics sector reveals where activities have shifted in the last year, and which struggles remain.

Antibody Engineering and Therapeutics

Post-event Report: Antibody Engineering & Therapeutics Virtual 2020

We look back at highlights of the recent Antibody Engineering & Therapeutics virtual conference.

Premium
Antibodies

Emerging Therapies Content Library: Whitepapers and Reports Collection

Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.

COVID-19

Life Sciences Survey: COVID-19 Impacts One Year On

COVID-19

Human Monoclonal Antibodies for SARS-CoV-2

Diversity and Inclusion

REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021

Neutralizing antibodies

Combating COVID-19: Identifying a Potential Drug Candidate for Human Testing in 90 Days - WEBINAR

Antibody Drug Conjugates

Developments in ADC Technology: Toxicity and Design Strategies

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 35,000+ antibody executives and scientists, including 2,100+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Kristin Skahan, Head of Portfolio Sales: 

kristin.skahan@informa.com | +1-857-504-6730

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2021 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.